Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.
Vanderbilt researchers have identified a key regulator of cell division.
Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.
Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.
New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.
A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.
Accessibility Tools